IE55223B1 - Disubstituted polymethylene imines,processes for their preparation and pharmaceutical compositions containing them - Google Patents

Disubstituted polymethylene imines,processes for their preparation and pharmaceutical compositions containing them

Info

Publication number
IE55223B1
IE55223B1 IE696/83A IE69683A IE55223B1 IE 55223 B1 IE55223 B1 IE 55223B1 IE 696/83 A IE696/83 A IE 696/83A IE 69683 A IE69683 A IE 69683A IE 55223 B1 IE55223 B1 IE 55223B1
Authority
IE
Ireland
Prior art keywords
bis
piperidine
general formula
allylamino
radical
Prior art date
Application number
IE696/83A
Other languages
English (en)
Other versions
IE830696L (en
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of IE830696L publication Critical patent/IE830696L/xx
Publication of IE55223B1 publication Critical patent/IE55223B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IE696/83A 1982-03-30 1983-03-29 Disubstituted polymethylene imines,processes for their preparation and pharmaceutical compositions containing them IE55223B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8205373A FR2524467A1 (fr) 1982-03-30 1982-03-30 Polymethylene-imines disubstituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant

Publications (2)

Publication Number Publication Date
IE830696L IE830696L (en) 1983-09-30
IE55223B1 true IE55223B1 (en) 1990-07-04

Family

ID=9272531

Family Applications (1)

Application Number Title Priority Date Filing Date
IE696/83A IE55223B1 (en) 1982-03-30 1983-03-29 Disubstituted polymethylene imines,processes for their preparation and pharmaceutical compositions containing them

Country Status (14)

Country Link
US (1) US4514398A (cg-RX-API-DMAC7.html)
EP (1) EP0090733B1 (cg-RX-API-DMAC7.html)
JP (1) JPS58180482A (cg-RX-API-DMAC7.html)
AT (1) ATE16286T1 (cg-RX-API-DMAC7.html)
AU (1) AU559376B2 (cg-RX-API-DMAC7.html)
CA (1) CA1206150A (cg-RX-API-DMAC7.html)
DE (1) DE3361100D1 (cg-RX-API-DMAC7.html)
ES (1) ES8405273A1 (cg-RX-API-DMAC7.html)
FR (1) FR2524467A1 (cg-RX-API-DMAC7.html)
IE (1) IE55223B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ203724A (cg-RX-API-DMAC7.html)
OA (1) OA07358A (cg-RX-API-DMAC7.html)
PT (1) PT76470B (cg-RX-API-DMAC7.html)
ZA (1) ZA832214B (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58128002A (ja) * 1982-01-25 1983-07-30 Sony Corp 記録再生装置
FR2544315B1 (fr) * 1983-04-12 1985-07-05 Adir Polymethylene imines disubstituees, leurs procedes de preparation, et les compositions pharmaceutiques les renfermant
FR2567518B1 (fr) * 1984-07-11 1987-11-13 Sanofi Sa Nouveaux composes a noyau heterocyclique azote, leur preparation et les medicaments qui en contiennent
US5243047A (en) * 1988-02-15 1993-09-07 Imperial Chemical Industries Plc Triazole/thiazole amino-s-triazine bonding agents
JP2614921B2 (ja) * 1989-07-05 1997-05-28 帝人株式会社 ２，４，６―三置換―ｓ―トリアジン誘導体，及びその製造方法
GB9024617D0 (en) * 1989-12-05 1991-01-02 Ici Plc Heterocyclic compounds
GB8929022D0 (en) * 1989-12-22 1990-02-28 Ici Plc Diazine derivatives
GB9008818D0 (en) * 1990-04-19 1990-06-13 Ici Plc Amine derivatives
FR2664594B1 (fr) * 1990-07-11 1992-09-18 Adir Polymethylene-imines disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
FR2667243B1 (fr) * 1990-09-27 1994-11-04 Adir Utilisation de s derives de la triazine et de la pyrimidine pour l'obtention de medicaments reversant la resistance aux agents anticancereux et antimalariques.
FR2673627B1 (fr) * 1991-03-07 1993-05-07 Adir Triazines et pyrimidines trisubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
JPH07506084A (ja) * 1991-11-12 1995-07-06 ファイザー　インク． 抗腫瘍活性増強用のトリアジン誘導体
KR100238346B1 (ko) * 1993-04-07 2000-03-02 오쓰까 아끼히꼬 피페리딘 유도체를 유효성분으로 하는 말초혈관확장제
WO1997040010A1 (en) * 1996-04-24 1997-10-30 Emory University Halogenated naphthyl methoxy piperidines for mapping serotonin transporter sites
US6943161B2 (en) * 1999-12-28 2005-09-13 Pharmacopela Drug Discovery, Inc. Pyrimidine and triazine kinase inhibitors
MY142362A (en) 2004-01-29 2010-11-30 Otsuka Pharma Co Ltd Pharmaceutical composition for promoting angiogenesis
CN103476769B (zh) 2010-10-27 2016-06-01 沃尔特及伊莱萨霍尔医学研究院 抗癌剂
US10023565B2 (en) 2013-12-20 2018-07-17 Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China N,N′ substituted piperidinamine compounds, and preparation method and usage thereof
JP2020536045A (ja) 2017-01-17 2020-12-10 デイヴィッド フォレスト マイケル Ａｔｐ合成酵素のリバースモードの治療的阻害剤
BR112019028172A2 (pt) 2017-07-13 2020-10-06 Michael David Forrest moduladores terapêuticos do modo reverso da atp sintase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL277028A (cg-RX-API-DMAC7.html) * 1961-04-19
US3362221A (en) * 1964-06-30 1968-01-09 Hays Corp Magnetic flow transmitter system
US3270014A (en) * 1965-07-01 1966-08-30 Upjohn Co 1, 2-dihydro-1-hydroxy-1, 3, 5-triazines
US3576805A (en) * 1969-05-22 1971-04-27 American Cyanamid Co N**2,n**4,n**6-trisubstituted melamines

Also Published As

Publication number Publication date
NZ203724A (en) 1985-12-13
PT76470A (fr) 1983-04-01
ES521191A0 (es) 1984-06-01
JPS58180482A (ja) 1983-10-21
ATE16286T1 (de) 1985-11-15
OA07358A (fr) 1984-08-31
AU559376B2 (en) 1987-03-05
FR2524467B1 (cg-RX-API-DMAC7.html) 1984-05-11
FR2524467A1 (fr) 1983-10-07
EP0090733B1 (fr) 1985-10-30
EP0090733A1 (fr) 1983-10-05
US4514398A (en) 1985-04-30
PT76470B (fr) 1986-03-11
CA1206150A (fr) 1986-06-17
ZA832214B (en) 1983-12-28
DE3361100D1 (en) 1985-12-05
IE830696L (en) 1983-09-30
AU1296783A (en) 1983-10-06
ES8405273A1 (es) 1984-06-01

Similar Documents

Publication Publication Date Title
IE55223B1 (en) Disubstituted polymethylene imines,processes for their preparation and pharmaceutical compositions containing them
US4524206A (en) 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
EP0370498A2 (en) Trans-4-amino(alkyl)-1-pyridylcarbamoylcyclohexane compounds and pharmaceutical use thereof
AU2002357619A1 (en) Piperazine derivative
KR100388568B1 (ko) 피리미디닐피라졸유도체와이의염및이를포함하는항종양제
EP0384228A1 (en) Medicament for treating cerebral insufficiency diseases containing 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives, and process for the production thereof
SK141998A3 (en) Piperidines and pyrrolidines
US4514399A (en) N-N'substituted polymethylene diamines
US5244894A (en) 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their use in therapeutics
AU771234B2 (en) Antidepressant heterocyclic compounds
JP3007203B2 (ja) ピペラジン誘導体
IE41648B1 (en) 2-substituted-piperidinyl or tetrahydropyridinyl)alkyl-1h-benz de isoquinoline-1,3(2h)-diones
EP1560815B1 (de) Neue pyrimidin-4,6-dicarbons urediamide zur selektiven inhibierung von kollagenasen
US4492696A (en) Piperazine and homopiperazine compounds
IE57934B1 (en) New quinoleine derivatives,a process for their preparation and pharmaceutical compositions containing them
US4677104A (en) Antipsychotic fused-ring pyridinylpiperazine derivatives
US3840529A (en) 1-(1-(3-substituted-1-propenyl)-4-piperidyl)-2-oxobenzimidazolines
HU198476B (en) Process for producing piperidine derivatives and pharmaceutical compositions comprising such compounds
SK285764B6 (sk) 3-Tetrahydropyridin-4-yl indoly, spôsob ich prípravy, farmaceutická kompozícia, spôsob jej prípravya použitie zlúčenín na prípravu kompozície na liečenie porúch centrálneho nervového systému
CA1250291A (en) Psychogeriatric 1-(2-pyrimidinyl)-piperazinyl derivatives of 1-pyrrolidin-2-ones
NZ207820A (en) Triazine derivatives and pharmaceutical compositions
US5254560A (en) 2-piperidinylpyrimidine-4-carboxamide derivatives, and their use in therapeutics
US5166157A (en) Naphthyl piperazines useful as 5-HT1A receptor ligands
US5162321A (en) 1-naphthyl piperazines useful as 5-HT1A receptor ligands
IE69847B1 (en) Disubstituted polymethyleneimines a process for the preparation thereof and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MM4A Patent lapsed